Advertisement

Topics

Sandoz International GmbH Company Profile

17:13 EDT 18th June 2018 | BioPortfolio

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredients.In 2005, Sandoz acquired Hexal, one of Germany’s leading generics company, and Eon Labs, one of the fastest-growing generic pharmaceuticals companies in the US. These acquisitions significantly strengthen the Sandoz technology base, particularly in the application of “difficult-to-make” generics: transdermal patches, inhalation products, sustained-release implants and multi-particulate drug-delivery dosage forms. Also expanded are the traditionally strong capabilities in pharmaceuticals, biopharmaceuticals and anti-infectives.

Location

Industriestrasse 25
Holzkirchen
83607
Germany

Contact

Phone: 49 (0) 8024 476 0
Fax: 49 (0) 8024 476-2599
Email: info.sandoz@sandoz.com


News Articles [542 Associated News Articles listed on BioPortfolio]

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 15022018] Prices from USD $350

Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Sandoz International GmbH Mergers Acquisitions MA, Partnerships Alliances and In...

Biocon, Sandoz sign exclusive immunology and oncology biosimilars pact

Novartis AG, through its Sandoz International GMBH generics unit, entered a collaboration with Indian biotech Biocon Ltd. to develop, manufacture, and commercialize multiple immunology and oncology bi...

Sandoz to commercialize Pear's reSET digital therapeutics to combat substance abuse

Sandoz International GMBH will lead the commercialization of Pear Therapeutics Inc.'s reSET for substance use disorder (SUD) and reSET-O for opioid use disorder (OUD).

DGAP-News: Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz

Novartis Pharma GmbH: GET.ON, TelePark und Circumradius gewinnen Digitalen Gesundheitspreis von Novartis und Sandoz Deutschland/Hexal DGAP-News: Novartis Pharma GmbH / Schlagwort(e): Sonstiges Nov...

FDA declines proposed Rituxan biosimilar from Sandoz

The FDA has rejected approval of Sandoz’s biologics license application for GP2013, a proposed rituximab biosimilar, issuing a Complete Response Letter for the product.“While disappointed, Sandoz ...

FDA accepts Sandoz’s BLA for biosimilar adalimumab

The US Food and Drug Administration (FDA) has agreed to review the biologics licence application (BLA) submitted by Sandoz, division...Read More... The post FDA accepts Sandoz’s BLA for biosimilar a...

Novartis International AG: Sandoz receives positive CHMP opinion for proposed biosimilar infliximab

Novartis International AG / Sandoz receives positive CHMP opinion for proposed biosimilar infliximab . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for ...

Human medicines European public assessment report (EPAR): Pregabalin Sandoz GmbH, pregabalin, Revision: 4, Authorised

PubMed Articles [537 Associated PubMed Articles listed on BioPortfolio]

The Supreme Court Ruling in Sandoz v Amgen: A Victory for Follow-on Biologics.

Sandoz receives positive CHMP opinion for proposed biosimilar infliximab.

Correction to: Lonoctocog Alfa: A Review in Haemophilia A.

The article Lonoctocog Alfa: A Review in Haemophilia A, written by Zaina T. Al-Salama and Lesley J. Scott, was originally published Online First without open access. After publication in volume 77...

Mycobacterium Interjectum isolated from an immunocompetent host with lung infection.

Improved molecular diagnostic techniques have resulted in increased reporting of nontuberculous mycobacterial infections. A 40-year-old male immunocompetent individual presented with cough and fever o...

Ocular Impression-Taking-Which Material Is Best?

To assess the efficacy and effect on clinical signs of a polyvinylsiloxane (Tresident; Shütz Dental Group GmbH, Germany) compared with an irreversible hydrocolloid (Orthoprint; Zhermack SpA, Badia Po...

Clinical Trials [1018 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.

This study will compare safety and efficacy of a generic rifaximin tablet to the reference listed drug in the treatment of travelers' diarrhea. Additionally both the generic and reference ...

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fed Conditions.

To Demonstrate the Relative Bioavailability of Cefzil 500 mg Cefprozil Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cefzil 500 mg Cefprozil tablets under fasting conditions.

To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

The purpose of this study is to Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Following a 10 ml Dose Fasting Conditions.

Companies [1791 Associated Companies listed on BioPortfolio]

Sandoz GmbH

Nil

Lek Ljubljana Holding GmbH

Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for ac...

Sandoz Inc.

Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents...

Sandoz International GmbH

Sandoz, a Novartis company, is a world leader in generic pharmaceuticals. The company develops, manufactures and markets these medicines as well as pharmaceutical and biotechnological active ingredien...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

More Information about "Sandoz International GmbH" on BioPortfolio

We have published hundreds of Sandoz International GmbH news stories on BioPortfolio along with dozens of Sandoz International GmbH Clinical Trials and PubMed Articles about Sandoz International GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sandoz International GmbH Companies in our database. You can also find out about relevant Sandoz International GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record